SET/TAF-I 抗体 (Biotin)
-
- 抗原 See all SET/TAF-I (SET) 抗体
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
适用
- 人, 小鼠, 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This SET/TAF-I antibody is conjugated to Biotin
-
应用范围
- Western Blotting (WB)
- 交叉反应
- 人
- 预测反应
- Mouse,Rat,Dog,Cow,Horse,Chicken,Rabbit
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human SET
- 亚型
- IgG
- Top Product
- Discover our top product SET Primary Antibody
-
-
- 应用备注
-
WB: 1:100-1000, IHC-P: 1:100-500
Optimal working dilution should be determined by the investigator. - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 mg/mL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C for 12 months.
- 有效期
- 12 months
-
- 抗原
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
- 别名
- Set (SET 产品)
- 背景
- Optional[synonyms]: SET_HUMAN, Protein SET, HLA-DR-associated protein II, Inhibitor of granzyme A-activated DNase (IGAAD), PHAPII, Phosphatase 2A inhibitor I2PP2A (I-2PP2A), Template-activating factor I (TAF-I), 2PP2A, IGAAD, MRD58, TAF-I, I2PP2A, IPP2A2, PHAPII, TAF-IBETA,
- 基因ID
- 6418
- UniProt
- Q01105
- 途径
- Apoptosis
-